Investing Profile

Brian Atwood(19)

VCInvestor
Managing Director at Versant Ventures
Photo of Brian Atwood, Managing Director at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture

1 Investor

Connected to Adam Draper (Boost VC).

cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
13
$102.2M
CompanyStageDateRound SizeTotal Raised
Immune Design
Series COct 2013$49M
Series BJul 2010$32M
Series AJul 2008$18M
$99M
Co-investors: Bill Harrington (Osage University Partners)
Veracyte
Series CJun 2013$28M
Series BJun 2010$28M
$71M
Co-investors: Jesse Treu (Domain Associates), Brook Byers (Kleiner Perkins)
Five Prime Therapeutics
Private EquityApr 2012$10M
Series UnknownFeb 2005$45M
$55M
Co-investors: James Blair (Domain Associates), Brook Byers (Kleiner Perkins)
OpGen
Series CMar 2012$17M
Series BSep 2010$17M
Series UnknownSep 2007$24M
$74M
Co-investors: David Rubin (Merck Global Health Innovation Fund), Corey Mulloy (Highland Capital Partners)
Groove Biopharma
Series BDec 2011$6M
Series AApr 2010$4M
$10M
PhaseRx
Series AFeb 2008$20M
$20M
Co-investors: John Diekman (5am Ventures)